Auro Laboratories Ltd
₹0.00▲ +0.00 (+0.00%)
AUROLABORATORIESLTD·NSE·Healthcare
Market Cap
156.08 Cr
PE Ratio
34.20
Volume
—
Day High - Low
—
52W High-Low
317.00 - 159.00
₹0.00▲ +0.00 (+0.00%)
Market Cap156.08 Cr
PE Ratio34.20
Volume—
Day High - Low—
52W High-Low317.00 - 159.00
Auro Laboratories Ltd (AUROLABORATORIESLTD): company summary
Auro Laboratories Ltd (AUROLABORATORIESLTD) is a micro-cap Healthcare company valued at ₹156 crore operating in Pharmaceuticals on the NSE and BSE.
Auro Laboratories Ltd (AUROLABORATORIESLTD) is a micro-cap Healthcare company valued at ₹156 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been shrinking at -14.8% a year over three years; profit grew 12.8% a year, ahead of revenue — margins are expanding. Return on equity is 8.5%.
- Valuation multiples
- The stock trades at 34.2 times earnings, broadly in line with the Healthcare median of 32.0, 3.46 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
2.4/10
Poor
Fair Value
Sign in to see
ROE
8.49%
Average
P/E
34.20x
Fair
Debt / Equity
1.37
Elevated
Industry
Healthcare
Pharmaceuticals
Overall View
Poor
Price performance
52W₹159.00
₹317.00
DocStoX take
Held back by growth (1.1). Scored on 4 of 5 measures.
DocStoX score
Medium confidence2.4
/10
Poor
Quality
Solid
ROE 8.5%
Valuation
Expensive
P/E 34.2×
Growth
Flat
Revenue -9.6% 5Y CAGR
Risk
High risk
D/E 1.37
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹156 Cr
52W High / Low
₹317 / ₹159
Dividend Yield
0.00%
Promoter Holding
52.40%
EPS (TTM)
₹2.95
Book Value
₹74.36
Key highlights
- Profitable in all of the last 5 years
- Profit shrinking 13% a year
- Revenue shrinking 10% a year
1 Positive4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Auro Laboratories Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Auro Laboratories Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Auro Laboratories Ltd with peers
Auro Laboratories Ltd vs Sun Pharmaceutical Industries LimitedAuro Laboratories Ltd vs Divi's Laboratories LimitedAuro Laboratories Ltd vs Torrent Pharmaceuticals LimitedAuro Laboratories Ltd vs Apollo Hospitals Enterprise LimitedAuro Laboratories Ltd vs Zydus Lifesciences LimitedAuro Laboratories Ltd vs Laurus Labs Limited
Related tools & concepts
Value Auro Laboratories Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing